The global at-home beauty device market is currently valued at $14.4 billion and is projected to reach $21.85 billion by 2030, according to the report. This growth is fueled by consumers seeking clinic-level results without the recurring appointments and expenses.
At-home beauty devices, such as LED masks and microcurrent lifting wands, are becoming increasingly popular. These devices are no longer confined to dermatology clinics and celebrity facialists’ treatment rooms, but are now sitting alongside toothbrushes and serums in bathroom cabinets across the world, making beauty more accessible.
The category is also expanding rapidly thanks to a growing ecosystem of new technology, including radiofrequency devices, at-home microneedling tools, NAD+ injectable pens, and sleep tech. Many of these products are still emerging, but industry experts see this wave of innovation as the next potential gold rush in beauty and wellness.
As beauty tools edge closer to medical territory, experts warn that the line between skincare and procedure is becoming harder to define. Dr. Michael Moore, an aesthetic practitioner, notes that once you are penetrating the skin, injecting substances, creating controlled injury, or trying to remodel tissue, you are no longer simply doing skincare, but performing a medical or quasi-medical procedure.
The marketing often focuses on the device or the product, but the real value comes from the practitioner’s knowledge, according to Dr. Moore. This raises concerns about the safety and effectiveness of at-home beauty devices, particularly those that involve breaking the skin barrier or require professional assessment and hygiene protocols.
NAD+ (nicotinamide adenine dinucleotide) is a naturally occurring coenzyme found in every cell of the body that plays a key role in DNA repair and cellular function. It has gained cultural momentum in recent years, amplified by figures such as Hailey Bieber, Kendall Jenner, Gwyneth Paltrow, and Jennifer Aniston. NAD+ therapies are not FDA-approved as anti-aging or wellness indications, but demand is growing, with the global NAD+ market valued at $184 million in 2022 and expected to reach $655 million by 2028.
Dr. Jonathan Leary, founder and CEO of social wellness club Remedy Place, has released an NAD+ pen needle designed for at-home use. The device is positioned as one of the most potent options on the market, bringing clinical-grade NAD+ therapy into a more accessible format that can be self-administered, often stored in a tote bag for convenience.
The design of these products is also evolving to reduce friction and intimidation. Dr. Leary explains that his cartridge-based injection pens allow users to twist to a desired dosage, swap disposable tips, and administer treatments without handling vials or syringes manually.
At-home microneedling has also been on the rise, despite traditionally sitting firmly within the remit of clinics. Brands such as Dr. Pen and Vita Vitae Beauty have helped drive the trend, offering handheld microneedling pens that create controlled micro-injuries in the skin to stimulate collagen production and enhance product absorption.
Radiofrequency is also emerging as a likely breakout category. Traditionally, radiofrequency therapy is performed in aesthetic clinics or dermatology practices, but at-home RF devices aim to replicate aspects of this technology in a safer, lower intensity format.
Sleep is another relatively unexplored frontier that’s ripe for at-home devices. Alexandra Zatarain, co-founder and VP of brand and marketing at Eight Sleep, notes that people are finally waking up to the fact that sleep is the most important pillar of health. Eight Sleep is focused on using AI, biometrics, and real-time interventions to improve sleep while it’s happening, which can be beneficial when trying to study techniques for better rest.
As at-home devices become increasingly sophisticated, the industry is confronting a central tension: the closer a treatment moves to clinical efficacy, the more clinical-level risk it begins to carry. This is why some brands have opted to avoid certain categories entirely, such as microneedling, which carries a higher risk profile and requires professional assessment and hygiene protocols.
Chris Hedges, VP of design and engineering at Shark Beauty, notes that the decision comes down to one key factor: can this be delivered safely, consistently, and effectively without clinical supervision? If the answer is yes, it may be suitable for the home, but if not, it belongs firmly in the hands of a professional.
Transparency is becoming a way to address concerns about product quality and safety. Dr. Leary says that his NAD+ pens incorporate traceability features designed to reassure consumers, including a barcode that allows users to access testing, certifications, and reports directly.
Many clinicians argue that there are limits to what should ever migrate into the home. Dr. Moore notes that all injectables should remain in a clinical setting, including botulinum toxin, fillers, skin boosters, polynucleotides, and exosomes, alongside more aggressive energy-based treatments and deeper microneedling procedures.
Ultimately, the next phase of the category is expected to move away from standalone hero gadgets and toward convergence. They will continue to get better, and we’ll see more topicals designed to be used alongside devices to enhance benefits, according to Hannah Mauser, senior beauty strategist at trend forecaster WGSN.
Leave a Reply